Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Aktuální cena Merck & Co Inc na trhu je 3 145,58 Kč s 24hodinovým objemem obchodování 9,79B Kč. Tržní kapitalizace aktiva je 7,76T Kč po změně o -1.32% za poslední den.
Tokenizovaný Merck & Co Inc se obchoduje za 3 170,39 Kč, s tokenizovanou tržní kapitalizací 7,95M Kč a 24hodinovým objemem obchodování 15,01M Kč. Tokenizované aktivum se posunulo o 0.14% za posledních 24 hodin.